Calidi Biotherapeutics, Inc. financial data

Symbol
CLDI on NYSE, CLDWW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4475 Executive Drive, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
First Light Acquisition Group, Inc. (to 9/19/2023)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.2 % +2.69%
Debt-to-equity -219 % -525%
Return On Equity 237 % +251%
Return On Assets -344 % -225%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.1M shares -63.1%
Common Stock, Shares, Outstanding 9.31M shares -73.7%
Entity Public Float 43.3M USD -81.1%
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 7.82M shares +447%
Weighted Average Number of Shares Outstanding, Diluted 7.82M shares +447%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11M USD -33.8%
Operating Income (Loss) -27.6M USD +19.9%
Nonoperating Income (Expense) 1.29M USD -97%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.3M USD +43.7%
Income Tax Expense (Benefit) 8K USD -72.4%
Net Income (Loss) Attributable to Parent -26.3M USD +8.59%
Earnings Per Share, Basic 15.9 USD/shares +53.9%
Earnings Per Share, Diluted 15.9 USD/shares +53.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 870 USD
Assets, Current 2.22M USD -81%
Property, Plant and Equipment, Net 982K USD
Operating Lease, Right-of-Use Asset 3.24M USD -25.3%
Other Assets, Noncurrent 217K USD +46.6%
Assets 6.66M USD -64.2%
Accounts Payable, Current 487K USD +1652%
Accrued Liabilities, Current 5.79M USD +1574%
Liabilities, Current 11.6M USD +6.49%
Operating Lease, Liability, Noncurrent 2.16M USD -33.1%
Other Liabilities, Noncurrent 1.5M USD
Liabilities 16.5M USD -16.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -74K USD -1750%
Retained Earnings (Accumulated Deficit) -118M USD -28.8%
Stockholders' Equity Attributable to Parent -11.8M USD +81.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.8M USD -796%
Liabilities and Equity 6.66M USD -64.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.83M USD -23.3%
Net Cash Provided by (Used in) Financing Activities 3.01M USD -20.5%
Net Cash Provided by (Used in) Investing Activities -5K USD +96.4%
Common Stock, Shares Authorized 330M shares 0%
Common Stock, Shares, Issued 9.31M shares -73.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -806K USD -247%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.12M USD -79.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 24K USD +100%
Deferred Tax Assets, Valuation Allowance 23.9M USD +53.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Cash and Cash Equivalents, Period Increase (Decrease) -465K USD
Deferred Tax Assets, Gross 25M USD +60.7%
Operating Lease, Liability 3.32M USD -22.6%
Depreciation 401K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -26.3M USD -154%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD -26.9%
Property, Plant and Equipment, Gross 2.28M USD
Operating Lease, Liability, Current 1.16M USD +17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD +3.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.43M USD +0.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 498K USD -46.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 526K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.2M USD +50.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 1.52M USD +22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16K USD
Operating Lease, Payments 349K USD +2.95%
Additional Paid in Capital 90.2M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 3.52M USD -37.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%